Category: News - Psychedelic Alpha

Our 2022 Year in Review is now live.

Read more about the article MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD

MAPS Wraps Second Phase 3 Trial of MDMA-Assisted Therapy for PTSD

Post published:November 17, 2022
Post category:News Press Release

Read more about the article BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics

BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics

Post published:August 1, 2022
Post category:News

Read more about the article Inside the Challenge to DEA’s Proposed Scheduling of 5 Psychedelic Tryptamines

Inside the Challenge to DEA’s Proposed Scheduling of 5 Psychedelic Tryptamines

Post published:July 29, 2022
Post category:Analysis News

Read more about the article Preparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to be?

Preparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to be?

Post published:November 5, 2021
Post category:Analysis News

Read more about the article Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre

Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre

Post published:September 27, 2021
Post category:News

Read more about the article Canadians Overwhelmingly Support Legal Access to Psilocybin-Assisted Therapy, Poll Reveals

Canadians Overwhelmingly Support Legal Access to Psilocybin-Assisted Therapy, Poll Reveals

Post published:August 4, 2021
Post category:News

Read more about the article Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and the Law

Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and the Law

Post published:June 30, 2021
Post category:Analysis News

Read more about the article Atai Targets $2.3bn Valuation in Nasdaq IPO

Atai Targets $2.3bn Valuation in Nasdaq IPO

Post published:June 11, 2021
Post category:News

Read more about the article Op-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance

Op-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance

Post published:June 4, 2021
Post category:News Op-ed

Read more about the article Psychedelics and Cannabis ETF Launches on NYSE Arca in First for the U.S.

Psychedelics and Cannabis ETF Launches on NYSE Arca in First for the U.S.

Post published:June 1, 2021
Post category:News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.